Victoria Brügger
Last Name
Brügger
First name
Victoria
Email
victoria.bruegger@unisg.ch
10 results
Now showing 1 - 10 of 10
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Early health technology assessment of digital diabetes screening in Switzerland: cost-effectiveness and budget impact analyses(2026-02-11); ; ;Magdalena Fuchs ;Qiuhan JinBenjamin WirthObjectives Digital biomarkers offer scalable screening for type 2 diabetes, yet adoption is stalled by uncertainty regarding economic viability. This study evaluates the cost-effectiveness and budget impact of digital screening compared to opportunistic screening from a Swiss payer perspective. Methods A probabilistic Markov cohort model was developed to simulate at-risk Swiss adults (age ≥45, BMI ≥25 kg/m²) over a 40-year horizon. The model incorporates a digital attrition parameter, inputs derived from Swiss-specific sources (e.g., the CoLaus study and FSO life tables), and statutory tariffs. Costs and outcomes were discounted at 3.0%. Results In the deterministic base-case, digital screening yielded an incremental cost-effectiveness ratio of CHF 2,912 per quality-adjusted life-year gained. Probabilistic sensitivity analysis indicated a 93.2% probability of cost-effectiveness at the CHF 50,000 threshold. The budget impact analysis estimated a Year 1 gross investment budget of CHF 27 million to identify prevalent cases, followed by long-term savings from averted complications. Conclusions Digital screening can be highly cost-effective in Switzerland. While the required Year 1 gross investment poses a liquidity challenge, reimbursement via pathway-oriented models under the Swiss tariff could align incentives with long-term complication avoidance.Type:journal articleJournal:MedRxiv - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Predicting postprandial glucose excursions to personalize dietary interventions for type-2 diabetes management(Springer Science and Business Media LLC, 2025-07-17); ; Mia JovanovaElevated postprandial glucose levels present a global epidemic and a major challenge in type-2 diabetes (T2D) management. A key barrier to developing effective dietary interventions for T2D management is the wide inter-individual variation in glycemic and behavioral responses, which limits the impact of one-size-fits-all recommendations. To enable personalized dietary prompts for glycemic control, it is critical to first predict an individual’s susceptibility to elevated postprandial (PPG) levels—or state of momentary vulnerability to PPG excursions. We examined the feasibility of personalized models to predict PPG excursions,and their associated vulnerability states, in the daily lives of 67 Chinese adults with T2D (Mage = 61.39; median = 63.00; 35 women; 2,463 glucose observations). We developed machine learning models trained on past individual observations to predict the next-in-time PPG excursion, using continuous glucose monitoring (CGM) data or CGM data combined with manually-logged meals and glucose-lowering agent intake. On average, personalized models predicted PPG excursions (F1-score: M = 75.88%; median = 78.26%), with substantial variation in predictability across individuals. Notably, no two individuals shared the same dietary and temporal predictors of PPG excursions. This study is the first to predict individual vulnerability states to glucose responses among adults with T2D in China. Findings can help personalize just-in-time adaptive interventions by tailoring dietary prompts based on individuals’ unique vulnerability states to PPG excursions. This approach can inform the development of digital dietary interventions in mHealth apps and clinical decision support tools, thereby helping optimize glycemic control and patient-centered T2D lifestyle management..Type:journal articleJournal:Scientific ReportsVolume:15Issue:1Scopus© Citations 9 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Wearables and Smartphones for Tracking Modifiable Risk Factors in Metabolic Health: Protocol for a Scoping ReviewBackground Metabolic diseases, such as cardiovascular diseases and diabetes, contribute significantly to global mortality and disability. Wearable devices and smartphones are increasingly used to track and manage modifiable risk factors associated with metabolic diseases. However, no established guidelines exist on how to derive meaningful signals from these devices, often hampering cross-study comparisons. Objective This study aims to systematically overview the current empirical literature on how wearables and smartphones are used to track modifiable (physiological and lifestyle) risk factors associated with metabolic diseases. Methods We will conduct a scoping review to overview how wearable and smartphone-based studies measure modifiable risk factors related to metabolic diseases. We will search 5 databases (Scopus, Web of Science, PubMed, Cochrane Central Register of Controlled Trials, and SPORTDiscus) from 2019 to 2024, with search terms related to wearables, smartphones, and modifiable risk factors associated with metabolic diseases. Eligible studies will use smartphones or wearables (worn on the wrist, finger, arm, hip, and chest) to track physiological or lifestyle factors related to metabolic diseases. We will follow the reporting guideline standards from PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) and the JBI (Joanna Briggs Institute) guidance on scoping review methodology. Two reviewers will independently screen articles for inclusion and extract data using a standardized form. The findings will be synthesized and reported qualitatively and quantitatively. Results Data collection is expected to begin in November 2024; data analysis in the first quarter of 2025; and submission to a peer-reviewed journal by the second quarter of 2025. We expect to identify the degree to which wearable and smartphone-based studies track modifiable risk factors collectively (versus in isolation), and the consistency and variation in how modifiable risk factors are measured across existing studies. Conclusions Results are expected to inform more standardized guidelines on wearable and smartphone-based measurements, with the goal of aiding cross-study comparison. The final report is planned for submission to a peer-reviewed, indexed journal. This review is among the first to systematically overview the current landscape on how wearables and smartphones measure modifiable risk factors associated with metabolic diseases. International Registered Report Identifier (IRRID) PRR1-10.2196/59539Type:journal articleJournal:JMIR Research ProtocolsVolume:13DOI:10.2196/59539Scopus© Citations 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Using Commercial Wearables for Lifestyle and Metabolic Phenotyping : A Study Protocol of the GLOW UP Study(2025-06-13); ; Jovanova, MiaThe GLOW UP (GLucose Observation and Wearable Utilisation Project) study assesses the predictive value of wearable-based lifestyle factors (e.g., physical activity, sleep, diet) for preventing type 2 diabetes (T2D). The study examines prediabetes primarily based on HbA1c and other glucose metabolism indicators, such as fasting plasma glucose and insulin resistance. By leveraging real-world data from commercially available wearables, the study explores whether lifestyle actors monitored in free-living conditions can predict early glucose metabolism abnormalities. The study also aims to assess the relative importance of each lifestyle factor, offering insights into personalized glucose dynamics and lifestyle patterns, potentially advancing personalized T2D prevention. This prospective case-control study involves 12 weeks of continuous lifestyle monitoring using wearables. Participants are adults aged 45 and above from Switzerland, selected based on specific criteria. Lifestyle behaviors, including physical activity, sleep, diet, stress, and substance use, are tracked via smartwatches and smartphone applications. Blinded continuous glucose monitoring is used to capture glucose profiles. Baseline and follow-up measurements include HbA1c, fasting glucose, insulin levels, and other metabolic markers. Predictive modeling, incorporating machine learning techniques like LASSO and time series models, will assess the relationship between lifestyle factors and glucose metrics. Additional clustering and regression analyses will examine the association between glucose profiles and metabolic characteristics. The study will evaluate the performance of wearable-derived lifestyle data in predicting HbA1c classifications as the primary outcome. Secondary outcomes include the predictive performance of wearable data on other metabolic markers (e.g., fasting plasma glucose, insulin resistance) and the feasibility of wearable-based individualized glucose profiling. Further analysis will explore lifestyle patterns across metabolic profiles, associations between lifestyle factors and glucose levels, and feature importance across metabolic subgroups. Findings are expected to provide detailed insights into how real-time lifestyle data can inform T2D risk at the individual level. The GLOW UP study has the potential to contribute to behavioral nutrition and physical activity fields by introducing a data-driven approach to T2D prevention through digital biomarkers. Anticipated findings may support the development of personalized, data-driven strategies for early T2D risk assessment and preventive healthcare in Switzerland and beyond.Type:conference poster - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Wearables and smartphones for tracking modifiable risk factors in metabolic health: a scoping review(2025-06-13); ; Jovanova, MiaMetabolic diseases, such as cardiovascular diseases and diabetes, are leading causes of death worldwide. Wearable devices and smartphones are increasingly used to monitor modifiable risk factors, including lifestyle behaviors such as nutrition, physical activity, stress, sleep, and substance use, as well as physiological markers, which can improve the management of metabolic diseases. This review will systematically scope the current literature to identify which modifiable (lifestyle and physiological) risk factors are most frequently studied in wearable and smartphone-based metabolic health research and to what extent measures of these risk factors are consistent across studies, particularly regarding measurement methods. A scoping review will be conducted to overview how wearable and smartphone-based studies measure modifiable risk factors related to metabolic diseases. Five databases (Scopus, Web of Science, PubMed, Cochrane Central Register of Controlled Trials, and SPORTDiscus) from 2019 to 2024, with search terms related to wearables, smartphones, and modifiable risk factors associated with metabolic diseases. Eligible studies will use smartphones and/or wearables (worn on the wrist, finger, arm, hip, and chest) to track physiological and/or lifestyle factors related to metabolic diseases. The review will follow reporting standards from PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) and JBI guidance on scoping review methodology. Two reviewers will independently screen articles for inclusion and extract data using a standardized form. Data collection is expected to begin in November; data analysis in the first quarter of 2025, and submission to a peer-reviewed journal by the second quarter in 2025. We expect to identify the degree to which wearable and smartphone-based studies track modifiable risk factors collectively (versus in isolation). Additionally, we will scope the consistency and variation in how modifiable risk factors are measured across existing studies. Results are expected to inform standardized guidelines on wearable and smartphone-based measurements, with the goal to aid cross-study comparison. The final report is planned for submission to a peer-reviewed journal. This review is among the first to systematically overview how wearables and smartphones measure modifiable risk factors associated with metabolic diseases and gaps in the measurement of these factors in digital metabolic health research.Type:conference poster - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Digital Diabetes Screening in Switzerland: A cost-effectiveness analysis(2025-11-14); ; ;Fuchs, Magdalena ;Jin, QiuhanWirth, BenjaminEarly identification of individuals at risk for type 2 diabetes (T2D) is critical for timely lifestyle intervention and prevention. While digital health applications offer a scalable and accessible approach to risk screening, their value depends on achieving sufficient accuracy to justify widespread use. This study aims to assess the cost-effectiveness of digital diabetes screening in Switzerland. A decision-analytic model was developed comprising a 1-year budget impact component and a 5-year cost-effectiveness analysis, consistent with established economic evaluation frameworks for diabetes screening. The target population consisted of 7 million Swiss adults aged 20 and above, with a 6% prevalence of T2D, of which 33% were assumed to be undiagnosed. The risk score was modeled as a two-step screening process, with assumed sensitivities ranging from 60% to 95% and specificities ranging from 90% to 99%, followed by confirmatory laboratory testing (e.g., HbA1c, FPG). Uptake scenarios ranged from 20% to 80%. Screening costs were considered based on available market prices, ranging from CHF 5 to CHF 120 per user, confirmatory testing at CHF 40, and initial treatment at CHF 200. Outcomes included new cases of T2D detected and quality-adjusted life years (QALYs) gained. Early detection was assumed to reduce the incidence of diabetes-related complications by 15% over 5 years. All parameters were sourced from published literature and Swiss public health data. In the base-case scenario (50% uptake, CHF 5 screening cost), the program identified 55,440 new T2D cases, with a 1-year net cost of CHF 38 million, equating to CHF 680 per case for statutory insurers (LaMal). Outpatient providers experienced a predominantly positive or neutral financial impact, benefiting from a larger diabetic population that allowed for earlier disease management. Over five years, the screening cost CHF 528.5 million and generated 528,917 QALYs, compared to CHF 657.2 million and 522,000 QALYs without screening. The incremental costeffectiveness ratio (ICER) was –CHF 18,565 per QALY gained, indicating that the screening was dominant (lower cost, higher benefit). Sensitivity analysis showed cost-effectiveness was maintained when specificity exceeded 90% and uptake surpassed 30%. These thresholds mark critical conditions under which the screening remains economically viable. Our analysis indicates that integrating digital diabetes screening into outpatient care in Switzerland is economically dominant under realistic assumptions. This approach offers substantial potential for cost-effective early detection and significant system-level savings, making it a valuable addition to national preventive health strategies.Type:conference posterJournal:Annual Meeting of the Swiss Society of Endocrinology and Diabetology (SGED-SSED 2025) - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Reminder Strategies to Improve Meal-Logging Adherence: Micro-Randomized Trial Protocol (Preprint)(JMIR Publications Inc., 2026-05-04) ;Magdalena Fuchs; ;Qiuhan Jin ;Benjamin WirthStefan BilzBackground: Accurate measurement of lifestyle factors is central to understanding how daily behaviors act as risk factors or protective buffers to non-communicable diseases. While wearable devices enable passive monitoring of physical activity or sleep, nutritional intake still depends on active participant input such as manual dietary logs or image-based recordings. Adherence to such logging tasks often declines rapidly, impacting data completeness and clinical utility. Theory-based reminders drawing on loss-framing or logging consistency feedback (i.e., tracking streaks) can improve adherence to lifestyle data collection, but effects of these strategies on repeated dietary logging remain unclear. Objective: To examine examines the effects of two theory-driven reminder strategies, loss-framing and logging consistency, on adherence to repeated, image-based meal-logging. Methods: We employ a micro-randomized trial (MRT) embedded within a 4-week observational lifestyle phenotyping study in Switzerland (N=200, age ≥45, BMI ≥25 kg/m²). Participants photograph their meals at each mealtime (breakfast, lunch, dinner) using a mobile app over 28 days. A decision point is scheduled prior to participant-defined habitual mealtimes. Participants are randomly assigned with equal probability to: (1) a reminder emphasizing loss of a daily financial reward for not logging ("loss-framing"), (2) a reminder providing feedback on recent logging consistency ("logging consistency"), or (3) a neutral reminder ("active control"). The proximal outcome is whether the participant logs a meal within two hours of receiving a reminder. Participants earn a daily financial reward contingent on meal logging completion. To estimate intervention effects, we will use marginal excursion effect models for binary outcomes, adjusting time-varying covariates (e.g., day in study) and baseline covariates (e.g., age, gender). Ethics approval for this study was granted by the Cantonal Ethics Committee of Eastern Switzerland (BASEC ID: 2025-00972). Results: Enrollment began in November 2025, and the study was initiated on December 8, 2025, with an anticipated completion date of January 2027. Conclusions: By clarifying the proximal effects of loss-framed and consistency-based reminders, findings will inform the design of future digital health studies to improve meal-logging adherence in daily life. This work contributes to the development of scalable, theory-driven reminder strategies for enhancing dietary data quality in observational and interventional research. Clinical Trial: ClinicalTrials.gov NCT07555262; https://clinicaltrials.gov/study/NCT07555262 ClinicalTrials.gov NCT07373418; https://clinicaltrials.gov/ct2/show/NCT07373418Type:working paperJournal:JMIR Preprints - Some of the metrics are blocked by yourconsent settings
Item type:Publication, GLOW UP Study: Protocol for an Observational Digital Biomarker Study for Prediabetes Screening and Digital Phenotyping(medRxiv, 2026-03-12); ;Fuchs, Magdalena ;Jin, Qiuhan ;Wirth, BenjaminBilz, StefanIntroduction Prediabetes, a key precursor to type 2 diabetes, is highly prevalent and underdiagnosed, particularly among adults aged ≥45 years with elevated body mass index (BMI). Early detection is critical because lifestyle interventions can delay or prevent progression to type 2 diabetes. The Glow Up (GLucose Observation and Wearable Use for Prevention) study aims to (1) test the feasibility of a digital biomarker for prediabetes screening using wearable– and smartphone-derived lifestyle factors (e.g., sleep, physical activity, and nutrition patterns), in daily life and to (2) characterize individual– and metabolic subgroup-level variability in lifestyle factors and glycemic control. Specifically, we aim to examine how lifestyle factors relate to diabetes risk and identify personalized predictors of early metabolic dysregulation. Methods and analysis Glow Up is a prospective, single-center, observational case-control study conducted in Switzerland. Adults (N=200) aged ≥45 years with BMI ≥25 kg/m² will be recruited, including n=100 individuals with prediabetes and n=100 age– and sex-matched case-control normoglycemic controls. Participants will undergo four weeks of continuous monitoring using a blinded continuous glucose monitor (CGM), and commercial– and medical-grade wearables; e.g. capturing physical activity, sleep, and physiological markers (heart rate variability, heart rate and skin temperature); in addition to completing daily image-based meal logs, using smartphones. Glycated haemoglobin (HbA1c), fasting plasma glucose (FPG) and body anthropometrics will be collected at baseline and follow-up, four weeks apart. Primary outcomes include HbA1c and FPG, measured at approximately four week follow-up. Secondary outcomes include CGM metrics, lifestyle profiling (sleep, physical activity, stress, and nutrition), and adherence to image-based meal logging. Ethics and dissemination The study has received ethics approval from the Ethics Committee of Eastern Switzerland (BASEC ID.: 2025-00972). Results will be published in international peer-reviewed journals and at national and international conferences as posters, presentations, and articles. Summaries will be provided to the funders and personalized reports to participants. Trial registration number NCT07373418Type:working paperJournal:medRxiv - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Personalizing dietary interventions by predicting individual vulnerability to glucose excursions(2024); ; Mia JovanovaAbstract Elevated postprandial glucose levels pose a global epidemic and are crucial in cardiometabolic disease management and prevention. A major challenge is inter-individual variability, which limits the effectiveness of population-wide dietary interventions. To develop personalized interventions, it is critical to first predict a person’s vulnerability to postprandial glucose excursions—or elevated post-meal glucose relative to a personal baseline—with minimal burden. We examined the feasibility of personalized models to predict future glucose excursions in the daily lives of 69 Chinese adults with type-2 diabetes (Mage=61.5; 50% women; 2’595 glucose observations). We developed machine learning models, trained on past individual context and meal-based observations, employing low-burden (continuous glucose monitoring) or additional high-burden (manual meal tracking) approaches. Personalized models predicted glucose excursions (F1-score:M=74%; median=78%), with some individuals being more predictable than others. The low burden-models performed better for those with consistent meal patterns and healthier glycemic profiles. Notably, no two individuals shared the same meal and context-based vulnerability predictors. This study is the first to predict individual vulnerability to glucose excursions among a sample of Chinese adults with type-2 diabetes. Findings can help personalize just-in-time-adaptive dietary interventions to unique vulnerability to glucose excursions in daily live, thereby helping improve diabetes management.Type:working paperJournal:medRxiv - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Wearables and smartphones for modifiable risk factors in metabolic health: a scoping review protocol(2024); ; Mia JovanovaBackground Metabolic diseases, such as cardiovascular diseases and diabetes, contribute significantly to global mortality and disability. Wearable devices and smartphones increasingly track physiological and lifestyle risk factors and can improve the management of metabolic diseases. However, the absence of clear guidelines for deriving meaningful signals from these devices often hampers cross-study comparisons. Objective Thus, this scoping review protocol aims to systematically overview the current empirical literature on how wearables and smartphones are used to measure modifiable risk factors associated with metabolic diseases. Methods We will conduct a scoping review to overview how wearables and smartphones measure modifiable risk factors related to metabolic diseases. We will search six databases (Scopus, Web of Science, ScienceDirect, PubMed, ACM Digital Library, and IEEE Xplore) from 2019 to 2024, with search terms related to wearables, smartphones, and modifiable risk factors associated with metabolic diseases. We will apply the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) and Arksey and O’Malley’s scoping review methodology. Eligible studies will use smartphones and/or wearables (worn on the wrist, finger, arm, hip, and chest) to track physiological and/or lifestyle factors related to metabolic diseases. Two reviewers will independently screen articles for inclusion. Data will be extracted using a standardized form, and the findings will be synthesized and reported qualitatively and quantitatively. Results The study is expected to identify potential gaps in measuring modifiable risk factors in current digital metabolic health research. Results are expected to inform more standardized guidelines on wearable and smartphone-based measurements to aid cross-study comparison. The final report is planned for submission to an indexed journal. Conclusions This review is among the first to systematically overview the current landscape on how wearables and smartphones are used to measure modifiable risk factors associated with metabolic diseases.Type:working paperJournal:medRxiv